Less Ads, More Data, More Tools Register for FREE

Pin to quick picksResolute Mining Regulatory News (RSG)

Share Price Information for Resolute Mining (RSG)

Share Price is delayed by 15 minutes
Get Live Data
58.40    -3.80 (-6.11%)
Bid:
57.20
Ask:
60.00
Spread: 2.80 (4.895%)
Market Cap: £1.25b
RSG Live PriceLast checked at - London Stock Exchange

Intraday Resolute Mining Share Chart

Ravenswood Update

19 Jun 2024 09:25

RNS Number : 0476T
Resolute Mining Limited
19 June 2024
 

19 June 2024

 

Ravenswood Update

 

Resolute restructures Ravenswood Payments and receives A$30 million with further A$20 million due by September 2024

 

Resolute Mining Limited ('Resolute' or 'the Company') (ASX/LSE:RSG) is pleased to announce that it has received A$30 million from Ravenswood Gold Pty Ltd ("Ravenswood") the owner of the Ravenswood Gold Mine which the Company sold on 31 March 2020.

 

Resolute and Ravenswood have restructured the Gold Price Contingent Promissory Note and Vendor Financing Promissory Note to support the Ravenswood Mine in its financing.

 

Based on the original agreements between Resolute and Ravenswood, Resolute was due to receive a Gold Price Contingent Amount after cumulative ounces produced from Ravenswood exceeded 500,000oz of gold over a four-year period. The payment amount was dependent on certain bands linked to gold price:

· A$10 million if the average gold price is greater than A$1,900/oz;

· A$20 million if the average gold price is greater than A$1,975/oz;

· A$30 million if the average gold price is greater than A$2,050/oz;

· A$40 million if the average gold price is greater than A$2,075/oz; and

· A$50 million if the average gold price is greater than A$2,100/oz.

 

Resolute and Ravenswood have agreed to amend the Gold Price Contingent Promissory Note including that the requirements of the clause regarding Payment of Gold Price Contingent Amount of the Original Gold Price Contingent Promissory Note are deemed to have been met. Accordingly, the Gold Price Contingent Amount payable to Resolute is A$50 million (the highest payable amount) and is payable in two tranches as follows:

· A$30 million paid to Resolute and received on 19 June 2024; and

· A$20 million to be paid to Resolute no later than 30 September 2024.

 

Additionally, Resolute has amended the A$50 million Vendor Financing Promissory Note that was originally due in March 2027. The new structure is as follows:

· Reset the principal to the increased amount of A$64 million to account for capitalised accrued interest;

· Maintain the annual coupon at 6% until 30 June 2025 after which the annual coupon increases to 12%. Interest will be capitalised and is to be paid to Resolute upon maturity; and

· Promissory note maturity extended to 31 December 2027 but may be repaid early on future Ravenswood financings, liquidity event(s), or excess cash from Ravenswood.

 

The Upside Sharing Promissory Note (up to A$150 million) linked to the investment outcomes of Ravenswood for EMR Capital ("EMR") - one of the owners of Ravenswood - remains unchanged. This instrument is triggered on any liquidity event including disposal of Ravenswood or qualifying initial public offering.

 

The payment is determined by reference to the gross money multiple to EMR which is the gross proceeds (before payment of the Upside Sharing Payment) divided by the total capital invested in the acquisition, development and operation of Ravenswood by EMR.

 

Resolute will receive the Upside Sharing Payment from the owners of Ravenswood based on the amount by which the gross money multiple exceeds a minimum threshold up to a cap of A$150 million as follows:

· A$7.5 million for each 0.1 that the gross money multiple is above 2.5x up to 4.0x; and

· A$5 million for each 0.1 that the gross money multiple is above 4.0x. 

 

Chris Eger, CFO, commented,

"This restructuring of the Ravenswood payments is a positive credit enhancing development for Resolute and further strengthens the Company's cash position for our growth projects.

We will receive the highest-possible payment of A$50 million from the Gold Price Contingent Promissory Note whilst also supporting Ravenswood with their financing. The first A$30 million tranche has been received and the second A$20 million tranche is due no later than the end of Q3 2024. These payments, along with strong cash generation from our operations, will further bolster our liquidity position and balance sheet in H2.

In tandem, we have favourably amended the A$50 million Vendor Financing Promissory Note with the coupon being increased from 6% to 12% from 30 June 2025 until maturity at the end of 2027, providing further potential cash to Resolute.

This is a great outcome for both Companies and demonstrates the good business relationship we have engendered."

 

Authorised by Mr Terence Holohan, Managing Director and Chief Executive Officer

 

Contact

Resolute

Matthias O'Toole Howes,

Corporate Development and Investor Relations Manager

Matthias.otoolehowes@resolutemining.com

+44 203 3017 620

 

 

Public Relations

Jos Simson, Tavistock

resolute@tavistock.co.uk

+44 207 920 3150

 

Corporate Brokers

Jennifer Lee, Berenberg

+44 20 3753 3040

 

Tom Rider, BMO Capital Markets

+44 20 7236 1010

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDGIGDLXDBDGSC
Date   Source Headline
19th Jun 20249:25 amRNSRavenswood Update
3rd Jun 20247:00 amRNSAppendix 3X Andrew Wray
28th May 20247:38 amRNSChair Transition and Appointment of NED
23rd May 20248:32 amRNSResults of AGM
14th May 20247:26 amRNS2023 Sustainability Report
30th Apr 20247:07 amRNSMarch 2024 Quarterly Presentation
30th Apr 20247:07 amRNSMarch 2024 Quarterly Activities Report
26th Apr 20247:00 amRNSQuarterly Conference Call Details
23rd Apr 20247:25 amRNSAGM Notice of Access
23rd Apr 20247:19 amRNSNotice of Annual General Meeting
27th Mar 202412:04 pmRNSCorporate Governance Statement
27th Mar 202412:03 pmRNSAppendix 4G
27th Mar 202411:55 amRNS2023 Annual Report
26th Mar 20247:00 amRNSAGM Advanced Notice
25th Mar 20247:00 amRNSAppendix 3Z Mark Potts
25th Mar 20247:00 amRNSAppendix 3X Adrienne Parker
21st Mar 20247:00 amRNSDirector Changes
8th Mar 20247:00 amRNSOre Reserves and Mineral Resource Statement
29th Feb 20247:00 amRNSAppendix 4E & Preliminary Final Report
31st Jan 20248:01 amRNSDec-23 Quarterly Activity Report and 2024 Guidance
29th Jan 20247:00 amRNSQuarterly Conference Call Details
24th Jan 20247:00 amRNSMaiden Mineral Resource at Tomboronkoto
11th Jan 20248:00 amRNSChange of Company Secretary
30th Nov 20237:00 amRNSChange of Registered Office
31st Oct 20237:00 amRNSSeptember 2023 Quarterly Activities Report
26th Oct 20237:00 amRNSQuarterly Conference Call Details
13th Oct 20237:38 amRNSGroup 3 Year Forecast and Update to 2023 Guidance
5th Sep 20237:00 amRNSChange of Share Registry Address
4th Sep 20237:00 amRNSMineral Resources Increased at Syama North Project
29th Aug 20237:00 amRNSChange of Registered Office
22nd Aug 20237:55 amRNSSummary of Half Year Results
22nd Aug 20237:50 amRNSHalf Yearly Results and Accounts
27th Jul 20237:00 amRNSJune 2023 Quarterly Activities Report
25th Jul 20237:00 amRNSQuarterly Conference Call Details
19th Jun 20237:00 amRNSAppendix 3X - KEITH MARSHALL
19th Jun 20237:00 amRNSDirector appointment
25th May 20238:32 amRNSDetails of Voting at Annual General Meeting
2nd May 20237:00 amRNS2022 Sustainability Report
27th Apr 20237:00 amRNSMarch 2023 Quarterly Activities Report
20th Apr 20239:14 amRNSQuarterly Conference Call Details
18th Apr 20238:20 amRNSAGM Notice of Access
18th Apr 20238:17 amRNSNotice of Annual General Meeting
5th Apr 20237:00 amRNSAGM Advanced Notice
29th Mar 20237:00 amRNSReport on Payments to Governments
29th Mar 20237:00 amRNSAppendix 4G
29th Mar 20237:00 amRNS2022 Annual Report
29th Mar 20237:00 amRNSCorporate Governance Statement
8th Mar 20237:00 amRNSOre Reserves and Mineral Resource Statement
24th Feb 20237:00 amRNSPreliminary Financial Results Presentation
24th Feb 20237:00 amRNS2022 Preliminary Financial Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.